BAYN.DE · GER · Healthcare
Bayer Aktiengesellschaft
Also onConsensus Drift
Implied value per share
EUR 49.34
Market price
EUR 48.09
Implied upside
+2.6%
5-year forecast · Perpetuity growth terminal value · Mid-year discounting · Base case
Value Per Share
Same forecast, different terminal treatment. Percentages vs price.
Forecast Cashflows
Reporting currency (EUR). Outflows negative.
| Line | FY26 | FY27 | FY28 | FY29 | FY30 | CAGR |
|---|---|---|---|---|---|---|
| Revenue | EUR 44.0bn | EUR 42.4bn | EUR 40.9bn | EUR 39.5bn | EUR 38.1bn | -3.5% |
| EBIT | EUR 5.7bn | EUR 5.5bn | EUR 5.3bn | EUR 5.1bn | EUR 4.9bn | -3.5% |
| NOPAT | EUR 5.1bn | EUR 4.9bn | EUR 4.7bn | EUR 4.6bn | EUR 4.4bn | -3.5% |
| Add depreciation & amortisation | EUR 6.5bn | EUR 6.2bn | EUR 6.0bn | EUR 5.8bn | EUR 5.6bn | -3.5% |
| Less capital expenditure | EUR -6.5bn | EUR -6.2bn | EUR -6.0bn | EUR -5.8bn | EUR -5.6bn | -3.5% |
| Less increase in working capital | EUR 132.1m | EUR 127.4m | EUR 122.9m | EUR 118.6m | EUR 114.4m | +3.5% |
| Free cashflow to firm | EUR 5.2bn | EUR 5.0bn | EUR 4.9bn | EUR 4.7bn | EUR 4.5bn | -3.5% |
| Discount factor | 0.9678 | 0.9066 | 0.8492 | 0.7954 | 0.7450 | - |
| Present value | EUR 5.1bn | EUR 4.6bn | EUR 4.1bn | EUR 3.7bn | EUR 3.4bn | -9.6% |
| Present Value Of The Forecast | EUR 20.9bn | |||||
Discount Rate
Source shown per component. All overridable above.
| Risk-free rate | 2.60% | EUR assumption - no free live source available for this market (assumption) |
| Equity risk premium | 6.00% | Market assumption |
| Beta | 0.889 | Reported 0.834, pulled toward 1.0 (Blume) |
| Cost of equity | 7.93% | Risk-free + beta x equity risk premium |
| Cost of debt | 5.87% | Interest expense / average total debt |
| Market capitalisation | EUR 47.2bn | 56.4% of capital |
| Total debt | EUR 36.5bn | 43.6% of capital, book value as a proxy |
| Tax rate | 10.8% | Effective, capped at statutory |
| WACC | 6.76% | E/V x Re + D/V x Rd x (1 - t) |
Terminal Value
Perpetuity growth is intrinsic. The exit multiple defaults to the company's current EV/EBITDA, so it answers a different question - what the shares are worth if today's rating holds and EBITDA grows as forecast.
Perpetuity growth at 2.50%
73% of EV
- Forecast FCFF, final year
- EUR 4.5bn
- Capex at depreciation, working capital in reinvestment
- EUR 4.4bn
- Less reinvestment at g/ROIC (29.0% of NOPAT)
- EUR -1.3bn
- Capitalised
- EUR 3.1bn
- ROIC (reported)
- 8.6%
- Terminal value, undiscounted
- EUR 75.4bn
- Terminal value, discounted
- EUR 56.2bn
- Enterprise value
- EUR 77.1bn
- Less net debt
- EUR 28.6bn
- Equity value
- EUR 48.5bn
Exit at 8.5x EBITDA
76% of EV
- Terminal value, undiscounted
- EUR 89.7bn
- Terminal value, discounted
- EUR 66.8bn
- Enterprise value
- EUR 87.7bn
- Less net debt
- EUR 28.6bn
- Equity value
- EUR 59.1bn
Spread between methods: 20%.
Sensitivity
Value per share (EUR) by discount rate and long-run growth.
| Long-run growth | |||||
|---|---|---|---|---|---|
| Discount rate | 1.50% | 2.00% | 2.50% | 3.00% | 3.50% |
| 4.76% | 86.85 | 96.58 | 110.53 | 132.28 | 171.14 |
| 5.76% | 61.35 | 65.38 | 70.60 | 77.63 | 87.68 |
| 6.76% | 45.50 | 47.24 | 49.34 | 51.95 | 55.31 |
| 7.76% | 34.68 | 35.35 | 36.11 | 36.99 | 38.04 |
| 8.76% | 26.93 | 27.10 | 27.28 | 27.45 | 27.63 |
Outlined: this model. Green text: above today's price of 48.09. Shading: distance from this model's own value.
Priced In
What each input would have to be to justify the current price, one at a time.
| Input | Model | Implied | Gap |
|---|---|---|---|
| Revenue growth, every year | -3.5% | -3.9% | -0.4pp |
| EBIT margin | 13.0% | 12.8% | -0.2pp |
| Discount rate | 6.8% | 6.8% | +0.1pp |
Live formulas, not pasted numbers - edit a driver and the workbook reprices.
Yahoo Finance and RBA data. General information, not advice. Methodology.